Table 3.
Pharmacokinetic or parasitological parameter | Spearman's correlation coefficienta |
||||||
---|---|---|---|---|---|---|---|
Parasite clearance time |
Parasite reduction ratio |
P0 | |||||
50% | 90% | 100% | 24 h | 48 h | 72 h | ||
Parasite density at time zero (P0) | 0.204 | 0.025 | 0.377 | 0.002 | 0.028 | −1.410 | 1.000 |
PK parameters | |||||||
AS on day 0 | |||||||
AUC0–8 | 0.125 | 0.092 | 0.067 | −0.054 | −0.020 | −0.049 | 0.052 |
Cmax | 0.076 | 0.072 | 0.058 | −0.450 | 0.004 | 0.045 | 0.051 |
CL/F | −0.058 | 0.007 | 0.045 | −0.032 | −0.119 | −0.155 | −0.064 |
V/F | 0.050 | −0.027 | −0.006 | 0.007 | −0.015 | −0.067 | −0.035 |
DHA on day 0 | |||||||
AUC0–8 | 0.125 | 0.095 | 0.091 | −0.068 | −0.068 | −0.029 | 0.073 |
Cmax | 0.079 | 0.077 | 0.088 | −0.034 | −0.064 | −0.014 | 0.064 |
CL | −1.010 | −0.080 | −0.090 | 0.071 | 0.054 | 0.048 | −0.086 |
V/F | −0.088 | −0.026 | −0.060 | −0.015 | −0.052 | −0.012 | −0.191 |
DHA on day 6 | |||||||
AUC | 0.027 | 0.068 | 0.122 | −0.068 | −0.087 | −0.035 | 0.014 |
Cmax | 0.010 | 0.057 | 0.120 | −0.063 | −0.077 | −0.039 | −0.013 |
CL | 0.102 | 0.054 | −0.044 | −0.017 | −0.018 | −0.037 | −0.042 |
V/F | 0.034 | 0.040 | −0.022 | −0.008 | −0.053 | −0.013 | −0.087 |
In vitro drug susceptibility (IC50b) | |||||||
DHA | 0.200 | 0.117 | 0.223 | −0.104 | −0.098 | −0.217 | 0.262 |
AS | 0.242 | 0.157 | 0.223 | −0.118 | −0.073 | −0.170 | 0.294 |
LUM | −0.130 | −0.015 | −0.012 | −0.009 | −0.023 | 0.020 | −0.090 |
CQ | 0.057 | −0.060 | 0.041 | 0.092 | 0.047 | −0.042 | 0.181 |
Q | −0.178 | −0.149 | −0.114 | 0.123 | 0.093 | 0.108 | −0.118 |
MQ | −0.122 | −0.040 | −0.050 | 0.006 | 0.029 | 0.032 | −0.013 |
Spearman's correlation coefficients (ρ) of the indicated pharmacokinetic or parasitological parameter compared to the pharmacodynamic outcomes expressed as 50, 90, and 100% parasite clearance times and parasite reduction ratios at 24, 48, and 72 h. Statistically significant correlations are highlighted in boldface type (P < 0.05).
IC50s are 50% inhibitory drug concentrations in vitro.